financetom
Business
financetom
/
Business
/
Visa Insider Sold Shares Worth $2,298,952, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Visa Insider Sold Shares Worth $2,298,952, According to a Recent SEC Filing
Apr 2, 2024 7:08 AM

09:32 AM EDT, 04/02/2024 (MT Newswires) -- Ryan Mcinerney, Director, Chief Executive Officer, on April 01, 2024, sold 8,200 shares in Visa (V) for $2,298,952. Following the Form 4 filing with the SEC, Mcinerney has control over a total of 211,854 shares of the company, with 538 shares held directly and 211,316 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1403161/000112760224011652/xslF345X03/form4.xml

Price: 277.94, Change: -0.35, Percent Change: -0.12

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Merck Withdraws Biologics License Application for Patritumab Deruxtecan
Merck Withdraws Biologics License Application for Patritumab Deruxtecan
May 29, 2025
07:45 AM EDT, 05/29/2025 (MT Newswires) -- Merck & Co. ( MRK ) said Thursday that it has voluntarily withdrawn its biologics license application with Daiichi Sankyo seeking approval for patritumab deruxtecan in the US. The application was based on the HERTHENA-Lung01 phase 2 trial for the treatment of certain adult patients with non-small cell lung cancer. The company said...
United Airlines, JetBlue to Collaborate on Flights, Loyalty Programs
United Airlines, JetBlue to Collaborate on Flights, Loyalty Programs
May 29, 2025
07:45 AM EDT, 05/29/2025 (MT Newswires) -- United Airlines Holdings ( UAL ) and JetBlue ( JBLU ) said Thursday they are collaborating to give customers of both airlines more options to find flights as well as new ways to earn MileagePlus and TrueBlue points. Under the new project, called Blue Sky, MileagePlus customers can earn and use miles on...
Market Chatter: Toyota Aims to Sell 7 EV Models in US by Mid-2027
Market Chatter: Toyota Aims to Sell 7 EV Models in US by Mid-2027
May 29, 2025
07:47 AM EDT, 05/29/2025 (MT Newswires) -- Toyota Motor ( TM ) aims to have seven electric vehicle models in its US dealerships by the middle of 2027, Bloomberg News reported Thursday. Production of two American-made EV models is scheduled to start in 2026, according to the report. These would join three new imported EVs the Japanese automaker plans to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved